Suppr超能文献

天然产物作为 COVID-19 背景下基于家庭的预防和症状管理药物。

Natural products as home-based prophylactic and symptom management agents in the setting of COVID-19.

机构信息

Department of Biosciences, Sri Sathya Sai Institute of Higher Learning, Anantapur, India.

Engineering Technology Department, College of Technology, University of Houston, Sugar Land, Texas, USA.

出版信息

Phytother Res. 2020 Dec;34(12):3148-3167. doi: 10.1002/ptr.6794. Epub 2020 Aug 17.

Abstract

Coronavirus disease (COVID-19) caused by the novel coronavirus (SARS-CoV-2) has rapidly spread across the globe affecting 213 countries or territories with greater than six million confirmed cases and about 0.37 million deaths, with World Health Organization categorizing it as a pandemic. Infected patients present with fever, cough, shortness of breath, and critical cases show acute respiratory infection and multiple organ failure. Likelihood of these severe indications is further enhanced by age as well as underlying comorbidities such as diabetes, cardiovascular, or thoracic problems, as well as due to an immunocompromised state. Currently, curative drugs or vaccines are lacking, and the standard of care is limited to symptom management. Natural products like ginger, turmeric, garlic, onion, cinnamon, lemon, neem, basil, and black pepper have been scientifically proven to have therapeutic benefits against acute respiratory tract infections including pulmonary fibrosis, diffuse alveolar damage, pneumonia, and acute respiratory distress syndrome, as well as associated septic shock, lung and kidney injury, all of which are symptoms associated with COVID-19 infection. This review highlights the potential of these natural products to serve as home-based, inexpensive, easily accessible, prophylactic agents against COVID-19.

摘要

由新型冠状病毒(SARS-CoV-2)引起的冠状病毒病(COVID-19)已迅速在全球范围内蔓延,影响了 213 个国家或地区,确诊病例超过 600 万例,死亡约 37 万例,世界卫生组织将其归类为大流行。受感染的患者会出现发热、咳嗽、呼吸急促等症状,重症患者会出现急性呼吸道感染和多器官衰竭。这些严重症状的可能性会因年龄以及糖尿病、心血管或胸部问题等基础合并症,以及免疫功能低下而进一步增加。目前,尚无治疗药物或疫苗,治疗标准仅限于症状管理。生姜、 turmeric、大蒜、洋葱、肉桂、柠檬、印楝、罗勒和黑胡椒等天然产品已被科学证明对急性呼吸道感染具有治疗作用,包括肺纤维化、弥漫性肺泡损伤、肺炎和急性呼吸窘迫综合征,以及相关的败血症性休克、肺和肾损伤,这些都是与 COVID-19 感染相关的症状。本综述强调了这些天然产品作为基于家庭、廉价、易于获得的 COVID-19 预防剂的潜力。

相似文献

1
Natural products as home-based prophylactic and symptom management agents in the setting of COVID-19.
Phytother Res. 2020 Dec;34(12):3148-3167. doi: 10.1002/ptr.6794. Epub 2020 Aug 17.
3
Natural Products Against COVID-19 Inflammation: A Mini-Review.
Comb Chem High Throughput Screen. 2022;25(14):2358-2369. doi: 10.2174/1386207325666220128114547.
5
[Comparison of clinical and pathological features between severe acute respiratory syndrome and coronavirus disease 2019].
Zhonghua Jie He He Hu Xi Za Zhi. 2020 Jun 12;43(6):496-502. doi: 10.3760/cma.j.cn112147-20200311-00312.
6
COVID-19: a conundrum to decipher.
Eur Rev Med Pharmacol Sci. 2020 May;24(10):5830-5841. doi: 10.26355/eurrev_202005_21378.
7
[Biological Product Development Strategies for Prevention and Treatment of Coronavirus Disease 2019].
Sichuan Da Xue Xue Bao Yi Xue Ban. 2020 Mar;51(2):139-145. doi: 10.12182/20200360506.
8
The novel zoonotic COVID-19 pandemic: An expected global health concern.
J Infect Dev Ctries. 2020 Mar 31;14(3):254-264. doi: 10.3855/jidc.12671.

引用本文的文献

4
Attitudes toward herbal medicine for COVID-19 in healthcare workers: A cross-sectional observational study.
Medicine (Baltimore). 2023 Sep 22;102(38):e35176. doi: 10.1097/MD.0000000000035176.
6
The Use of D-Optimal Mixture Design in Optimizing Formulation of a Nutraceutical Hard Candy.
Int J Food Sci. 2023 Mar 15;2023:7510452. doi: 10.1155/2023/7510452. eCollection 2023.
7
Plant-derived Ren's oligopeptide has antiviral effects on influenza virus and SARS-CoV-2.
Front Vet Sci. 2023 Feb 2;9:1090372. doi: 10.3389/fvets.2022.1090372. eCollection 2022.
10

本文引用的文献

2
Coronavirus disease 2019 (COVID-19): first indication of efficacy of Gene-Eden-VIR/Novirin in SARS-CoV-2 infection.
Int J Antimicrob Agents. 2020 Jun;55(6):105971. doi: 10.1016/j.ijantimicag.2020.105971. Epub 2020 Apr 10.
3
The effect of quarantine and isolation for COVID-19 in general population and dermatologic treatments.
Dermatol Ther. 2020 Jul;33(4):e13398. doi: 10.1111/dth.13398. Epub 2020 Apr 25.
4
COVID-19 transmission through asymptomatic carriers is a challenge to containment.
Influenza Other Respir Viruses. 2020 Jul;14(4):474-475. doi: 10.1111/irv.12743. Epub 2020 Apr 15.
5
Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 in Wuhan, China: a retrospective study.
Chin Med J (Engl). 2020 Jun 5;133(11):1261-1267. doi: 10.1097/CM9.0000000000000824.
6
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.
Int J Antimicrob Agents. 2020 Jul;56(1):105949. doi: 10.1016/j.ijantimicag.2020.105949. Epub 2020 Mar 20.
7
[Coronavirus disease 2019 (COVID-19): update for anesthesiologists and intensivists March 2020].
Anaesthesist. 2020 Apr;69(4):225-235. doi: 10.1007/s00101-020-00758-x.
8
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19.
N Engl J Med. 2020 May 7;382(19):1787-1799. doi: 10.1056/NEJMoa2001282. Epub 2020 Mar 18.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验